Mary is a Senior Lecturer and clinical epidemiologist and has worked at The Kirby Institute for the past eight years.Mary has been involved in the design and implementation of HIV prevention trials, both nationally and internationally. She completed her PhD on biomedical methods of HIV prevention in 2010. Her research interests include biomedical HIV prevention technologies, in particular post-exposure prophylaxis and their impact on HIV risk behaviour and also treatment modalities of anal dysplasia.
Mary is project leader of the Study of the Prevention of Anal Cancer (SPANC) investigating the natural history of anal dysplasia in gay men. She is currently involved in the implementation of the SPANC study, and is collaborating with international researchers on HPV seroprevalence, seroincidence and risk factors in HIV negative gay Australian men.